Prazosin hydrochloride
Reading File
Finding Sources
Searching PubMed
prazosin hydrochloride clinical use
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Here is a comprehensive overview of Prazosin Hydrochloride, drawn from Goodman & Gilman, Katzung, Lippincott, and psychiatric references.
Prazosin Hydrochloride
Drug class: Selective alpha-1 (α1) adrenergic receptor antagonist (quinazoline derivative)
Brand name: Minipress
Chemical & Structural Notes
Prazosin is a quinazoline-based compound. Its structural relatives include doxazosin and terazosin. The quinazoline ring moiety is pharmacologically important - it confers both receptor binding and, in congeners like terazosin/doxazosin, a pro-apoptotic effect on prostate smooth muscle cells.
Mechanism of Action
Prazosin blocks α1 adrenergic receptors with approximately 1000-fold greater selectivity over α2 receptors. It has similar potency at all α1 subtypes (α1A, α1B, α1D).
Cardiovascular effects:
- Inhibits catecholamine-induced vasoconstriction in both arterioles (resistance vessels) and veins
- Reduces peripheral vascular resistance and venous return (preload)
- Decreases afterload without a significant reflex tachycardia - because prazosin does NOT block α2 receptors, it does not enhance NE release from sympathetic terminals in the heart
- May also suppress sympathetic outflow centrally and depress baroreflex function
- Favorably affects lipid profiles: decreases LDL and triglycerides, increases HDL
Urological effects:
-
Relaxes smooth muscle in the prostate capsule, bladder neck, and prostatic urethra
-
Reduces resistance to urinary outflow in BPH
-
Goodman & Gilman's Pharmacological Basis of Therapeutics
Pharmacokinetics (ADME)
| Parameter | Value |
|---|---|
| Bioavailability | 50-70% (oral) |
| Time to peak plasma conc. | 1-3 hours |
| Plasma protein binding | ~95% (primarily α1-acid glycoprotein) |
| Metabolism | Extensive hepatic first-pass |
| Elimination | Primarily fecal (metabolites); minimal renal excretion of unchanged drug |
| Half-life (t½) | ~3 hours (prolonged to 6-8 h in CHF) |
| Duration of action | 7-10 hours (antihypertensive) |
Note: Diseases altering α1-acid glycoprotein (e.g., inflammatory states) can change the free fraction of prazosin in plasma.
- Goodman & Gilman's, Katzung's Basic & Clinical Pharmacology
Dosing
| Indication | Starting Dose | Usual Range |
|---|---|---|
| Hypertension | 1 mg at bedtime | Up to 20 mg/day (divided) |
| BPH (off-label) | 1 mg | 1-5 mg twice daily |
| PTSD nightmares | 1 mg at bedtime | Titrated upward per response |
The first dose must be given at bedtime to minimize risk of syncopal "first-dose effect."
Therapeutic Uses
-
Hypertension - Reduces blood pressure through arteriolar and venous dilation. Also provides pleiotropic benefit (improved lipid profiles, glucose-insulin metabolism in at-risk patients).
-
Benign Prostatic Hyperplasia (BPH) - Off-label; relaxes smooth muscle at bladder neck and prostate, rapidly improving urinary flow (unlike finasteride, which takes months). Often combined with finasteride for progressive BPH.
-
Congestive Heart Failure - Short-term benefit from reduced preload/afterload, but prazosin has NOT been shown to reduce mortality in CHF and is not a drug of choice.
-
Raynaud Syndrome - Some evidence for reducing digital vasospasm, though Ca2+ channel blockers are generally preferred.
-
PTSD-related nightmares - A well-established off-label use. Prazosin acts as a central α1 antagonist to suppress noradrenergic hyperarousal, significantly reducing trauma-related nightmares and increasing REM sleep. Evidence is growing but mixed (a major RCT vs. placebo showed limited benefit in some subpopulations). - Kaplan & Sadock's Comprehensive Textbook of Psychiatry
-
Spinal cord injury / neurogenic bladder - Helps bladder emptying in patients with parasympathetic decentralization.
Adverse Effects
First-dose effect (major concern):
- Marked postural hypotension and syncope occurring 30-90 minutes after the first dose
- Risk is higher in hypovolemic or salt-depleted patients
- Minimized by: starting at 1 mg at bedtime, slow upward titration, cautious addition of other antihypertensives
Other adverse effects:
- Orthostatic hypotension (chronic treatment) - check standing BP routinely
- Dizziness, headache, palpitations, asthenia, lassitude
- Positive antinuclear factor (ANA) test - not associated with clinical rheumatic disease
- Does NOT adversely affect lipids (may even improve them)
Drug Interactions & Precautions
- Other antihypertensives: Adding a second agent to a patient on high-dose prazosin can precipitate syncope
- PDE5 inhibitors (sildenafil, tadalafil): Risk of severe hypotension - use with caution
- Hepatic disease: Dose adjustment needed (extensive hepatic metabolism)
- CHF: t½ prolonged to 6-8 hours; monitor carefully
Comparison with Congeners
| Drug | Selectivity | t½ | Dosing | Special Features |
|---|---|---|---|---|
| Prazosin | α1 (all subtypes) | ~3 h | 2-3x/day | Prototype; shorter acting |
| Terazosin | α1 (all subtypes) | ~12 h | Once daily | Also induces prostate apoptosis |
| Doxazosin | α1 (all subtypes) | ~20 h | Once daily | Also induces prostate apoptosis |
| Tamsulosin | α1A selective | ~9-15 h | Once daily | Prostate selective; less hypotension |
Recent Evidence Note (PubMed 2024-2026)
Recent meta-analyses have specifically examined prazosin for PTSD:
- A 2025 meta-regression analysis (PMID 39828080) found that factors such as baseline nightmare severity, dose, and comorbidities impact prazosin's efficacy for PTSD-related nightmares and insomnia - suggesting patient selection matters significantly.
- Two 2024-2025 systematic reviews (PMIDs 39061119, 40665297) confirm prazosin remains one of the studied pharmacological options for PTSD sleep disturbance, though effect sizes are heterogeneous across trials.
Summary: Prazosin hydrochloride is the prototype α1-selective blocker - useful for hypertension, BPH, and PTSD nightmares. Its short half-life necessitates multiple daily doses. The first-dose hypotension risk is its most clinically important adverse effect and mandates bedtime initiation and careful titration.
Aiapget previous year questions from Raktapitta chapter chikitsa charak
Searching the Web
AIAPGET previous year questions Raktapitta chikitsa Charak samhita
Searching the Web
AIAPGET MCQ Raktapitta chikitsa sthana Charaka previous year exam questions
Reading Web Page
https://www.carakasamhitaonline.com/index.php/Raktapitta_Chi…
Here is a comprehensive set of AIAPGET-style MCQs from Raktapitta Chikitsa (Charak Chikitsa Sthana, Chapter 4), compiled from previous year patterns, standard sources, and key content from the chapter:
AIAPGET - Raktapitta Chikitsa (Cha. Chi. 4) - Previous Year & High-Yield Questions
CHAPTER BASICS
Q1. Raktapitta Chikitsa is the ______ chapter of Charaka Chikitsa Sthana?
- A) 2nd
- B) 3rd
- C) 4th ✓
- D) 5th
Q2. The chapter Raktapitta Chikitsa was expounded by?
- A) Agnivesha
- B) Charaka
- C) Atreya ✓
- D) Dridhabala
DOSHA CHARACTERISTICS (High-frequency AIAPGET topic)
Q3. Raktapitta with "Sandra, Sapandu, Sasneha, Picchila" characteristics is ______ doshaja?
- A) Vataja
- B) Pittaja
- C) Kaphaja ✓
- D) Sannipataja
Q4. Raktapitta which is "Shyava, Aruna, Saphena, Tanu, Ruksha" is ______ doshaja?
- A) Kaphaja
- B) Pittaja
- C) Vataja ✓
- D) Sannipataja
Q5. Raktapitta that is "Kashayabha, Krishna, Gomutra-sannibha, Mecaka, Agara-dhumabha" is ______ doshaja?
- A) Vataja
- B) Pittaja ✓
- C) Kaphaja
- D) Sannipataja
Q6. Sannipataja Raktapitta has ______ lingas?
- A) 1 (eka-linga)
- B) 2 (dwi-linga)
- C) 3 (tri-linga) ✓
- D) All of the above
CHIKITSA SIDDHANTA (Treatment Principles)
Q7. The primary line of treatment for Raktapitta according to Charaka is?
- A) Vamana
- B) Virechana ✓
- C) Basti
- D) Raktamokshana
Q8. In Raktapitta with Vata predominance, after Pitta and Kapha are controlled by Kashaya yogas, what should be done?
- A) Give Virechana
- B) Give Vamana
- C) Treat the Vata ✓ (Anila syad anu tatra karyam - Cha. Chi. 4/82)
- D) Give Langhana
Q9. Langhana (fasting/lightening) is the treatment of choice in ______ Raktapitta?
- A) Vataja
- B) Pittaja
- C) Kaphaja ✓
- D) Sannipataja
Q10. Which of the following is mentioned as "Paramaupayika" (most beneficial) diet in Raktapitta?
- A) Goat milk
- B) Chagam payah (goat's milk) ✓ (Cha. Chi. 4/83)
- C) Cow's milk
- D) Ghrita
Q11. Raktapitta with Urdhwagata (upward) bleeding is treated primarily with?
- A) Virechana ✓
- B) Vamana
- C) Basti
- D) Nasya
Q12. Adhogata Raktapitta (downward bleeding) is treated with?
- A) Virechana
- B) Vamana ✓
- C) Basti
- D) Langhana
DRAVYAS & FORMULATIONS (Most Tested)
Q13. "Sashakavishtambha" (with rabbit dung) is used in ______ of Raktapitta?
- A) Pittaja Raktapitta
- B) Vibandha (constipation) in Raktapitta patients ✓ (Cha. Chi. 4/49 - Shasha savastukah shasto vibandhe raktapittinaam)
- C) Vataja Raktapitta
- D) Urdhwagata Raktapitta
Q14. Mayura (peacock) prepared in Plaksha-niryuha is useful in which condition of Raktapitta?
- A) Vataja
- B) Pittaja
- C) Raktapitta with Ataulbana (severe thirst) ✓
- D) Kaphaja
Q15. Tittira (partridge) cooked in Udumbara rasa is indicated in Raktapitta with?
- A) Vibandha
- B) Vataulbana (Vata predominance with ataulbana) ✓ (Cha. Chi. 4/49)
- C) Murccha
- D) Trishna
Q16. Vaidurya, Mukta, Manigerika, Mricchankhahema, Amalakodaka, Madhudaka, Iksurasa - drinking these is mentioned for?
- A) Pandu
- B) Raktapitta ✓ (Cha. Chi. 4/79)
- C) Kamala
- D) Jwara
Q17. The combination of Mudga + Salaja + Sayava + Sakrishna + Soshira + Musta + Chandana, kept overnight in Bala-siddha jala is used for?
- A) Vibandha in Raktapitta
- B) Aggravated (udirna) Raktapitta ✓ (Cha. Chi. 4/78)
- C) Vataja Raktapitta only
- D) Kaphaja Raktapitta only
Q18. Chandanadya taila rogadhikara is?
- A) Jwara
- B) Raktapitta ✓
- C) Gulma
- D) Prameha
Q19. Tryushanaadi ghritam rogadhikara is?
- A) Raktapitta ✓
- B) Jwara
- C) Gulma
- D) Rajayakshma
NIDANA & PURVARUPA (Often asked cross-reference)
Q20. "Loha gandha during inspiration" is the Purvarupa of?
- A) Jwara
- B) Raktapitta ✓
- C) Rajayakshma
- D) Amlapitta
Q21. "Pravrutistu Parigrahat" is the etiological factor for?
- A) Prameha
- B) Jwara
- C) Kushtha
- D) Raktapitta ✓
Q22. "Mahagadam Mahavegam Agni-vachidraka-richa" - this description is for?
- A) Prameha
- B) Jwara
- C) Kushtha
- D) Raktapitta ✓
SADHYA-ASADHYATA (Prognosis)
Q23. According to Charaka, Raktapitta is ______ in its early stage?
- A) Asadhya
- B) Sadhya (curable) ✓
- C) Yapya
- D) Kriccha-sadhya
Q24. Urdhwagata Raktapitta is compared to which prognosis vs Adhogata?
- A) Both are equally Sadhya
- B) Urdhwagata is Sadhya; Adhogata is Krichrasadhya ✓
- C) Urdhwagata is Asadhya
- D) Both are Asadhya
CROSS-REFERENCE / TRICKY QUESTIONS
Q25. Mutrashmari (urinary calculi) is discussed in which chapter of Charaka Samhita?
- A) Prameha Chikitsa
- B) Raktapitta Chikitsa ✓
- C) Visha Chikitsa
- D) Trimarmiya Chikitsa
Q26. In Charaka Chikitsa, indications given for Tarpana Kalpa in Santarpaniya Adhyaya does NOT include?
- A) Jwara
- B) Mutra-kricchha
- C) Udara-vata
- D) Raktapitta ✓
KEY MNEMONICS TO REMEMBER
| Feature | Vataja RP | Pittaja RP | Kaphaja RP |
|---|---|---|---|
| Color | Shyava/Aruna | Krishna/Gomutrabha | Pandu/Pita |
| Consistency | Tanu, Ruksha | Drava | Sandra, Picchila |
| Treatment | Snehana, Vata-hara | Virechana | Langhana, Vamana |
Note: AIAPGET does not release official previous year question papers publicly, so these questions are compiled from:
- Documented exam patterns shared by coaching institutes (Drona Institute, Dr. Ajit Patil's notes)
- Standard MCQ banks based on Cha. Chi. 4 content
- Cross-referenced from Bharati Vidyapeeth MCQ PDF and other PG entrance resources
For the most authentic previous year papers, check the NTA AIAPGET official portal or coaching material from institutes like Drona, RAU, or Shri Dhanvantari.
This is a shared conversation. Sign in to Orris to start your own chat.